AEON Stock Analysis: Buy, Sell, or Hold?
AEON - AEON Biopharma, Inc.
$0.28
0.00 (0.11%)
â˛
5d:
-5.97%
30d:
-42.58%
90d:
-69.18%
WAIT
LOW Confidence
Analysis Updated: Aug 10, 2026 12:00 AM ET
Earnings: Aug 11, 2026
0d
Get Alerted When AEON Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
âšī¸ NEUTRAL: AEON is fairly priced but lacks strong directional signals. Wait for clearer setup or better entry on dips.
âšī¸ NEUTRAL: AEON is fairly priced but lacks strong directional signals. Wait for clearer setup or better entry on dips.
In-depth Analysis How we analyze
Valuation Analysis: AEON is currently trading at $0.28, which is considered fair relative to its 30-day fair value range of $0.21 to $0.49.
Technical Outlook: Technically, AEON is in a strong downtrend. Immediate support is located at $0.23, while resistance sits at $0.34.
Market Sentiment: The stock scores a mixed 41/100 on our bottoming-setup gauge, with only partial signs of a stabilized entry point. Wall Street analysts see significant upside, with an average price target of $4.80 (+1630.4%). Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, AEON is in a strong downtrend. Immediate support is located at $0.23, while resistance sits at $0.34.
Market Sentiment: The stock scores a mixed 41/100 on our bottoming-setup gauge, with only partial signs of a stabilized entry point. Wall Street analysts see significant upside, with an average price target of $4.80 (+1630.4%). Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
FAIR
Historical Trading Range
$0.21 -
$0.49
Company Quality Score
42/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
74.7%
All Signals
- NEUTRAL: Price in fair range
- NEUTRAL: Mixed technical signals (41/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 1630.4% below Wall St target ($4.80)
- WARNING: Composite score 42/100 in the bottom quintile â this cohort historically lags the market
Trading Range Analysis
30-Day Trading Range
$0.21 -
$0.49
Current vs Trading Range
FAIR
Support & Resistance Levels
Support Level
$0.23
Resistance Level
$0.34
Current Trend
Strong Downtrend
Technical data as of
Aug 10, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-0.53
Wall Street Target
$4.80
(+1630.4%)
Share & Embed Analysis
Last updated: August 11, 2026 5:10 AM ET
Data refreshes hourly during market hours. Next update: 6:10 AM
Data refreshes hourly during market hours. Next update: 6:10 AM
đĨ Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is AEON showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
CYTK
Cytokinetics Inc |
STRONG BUY
21 analysts |
$108 | 58 HOLD |
|
CRSP
Crispr Therapeutics AG |
BUY
28 analysts |
$88 | 44 HOLD |
|
INSM
Insmed Inc |
STRONG BUY
21 analysts |
$198 | 28 SELL |
|
BHVN
Biohaven Ltd. |
STRONG BUY
16 analysts |
$23 | 53 HOLD |
|
CRNX
Crinetics PharmaceuticalâĻ |
STRONG BUY
17 analysts |
$86 | 48 HOLD |
